eSense-Lab

Reverse-engineered Cannabis Terpene Profiles

Health Tech & Life Sciences
Non Active, Apr 2023 ceased to operate
Mature Ness Ziona, Israel Founded 2016
LinkedIn
Last updated 2026-06-18
Total raised
$2.5M
Stage
Mature
Founded
2016
Headcount
1-10
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences

About

eSense-Lab is a pharmatech company that is re-engineering the chemical composition of plants, starting with cannabis, in order to reformulate them for commercial applications. The company applies cutting-edge technologies and disruptive techniques to reverse engineer rare or lucrative plants, deconstructing the chemical profiles and using alternate natural products to then re-engineer and create the virtual plant. The result is a line of plant-based products with commercial and medicinal applications, viable for multiple markets and mass consumer consumption. eSense-Lab is an Israel-based life sciences research and development company listed on the ASX (ESE).

Q&A

What is eSense-Lab's primary business?
eSense-Lab is a pharmatech company focused on reverse-engineering the chemical composition of plants, particularly cannabis, to reformulate them for commercial and medicinal applications.
When was eSense-Lab founded?
eSense-Lab was founded in April 2016.
What is the current status of eSense-Lab?
eSense-Lab is currently inactive, having ceased operations in April 2023.
Where is eSense-Lab headquartered?
eSense-Lab is headquartered in Ness Ziona, Center District, Israel.
What is eSense-Lab's employee count?
eSense-Lab has an employee count in the 1-10 range.
What is the total amount of funding eSense-Lab has raised?
eSense-Lab has raised a total of $2,480,070 USD.
What is eSense-Lab's primary sector?
eSense-Lab's primary sector is Health Tech & Life Sciences.
Does eSense-Lab hold any patents?
Yes, eSense-Lab holds 1 patent.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
BiologicalsHerbals
Target customers
ConsumersRecreational & LifestyleCannabisHealthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

pharmaceuticalspharma-companiescannabisherbal-medicineplant-genomics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)